Menu
Back to User profile » Dr Haiyong Wang
Papers published by Dr Haiyong Wang:
Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8+ T Cell Infiltration in Chinese Pulmonary Sarcomatoid Carcinoma
Zhang C, Li Z, Zhang Y, Zhao C, Wang H, Lin J, Liu C, Wang X, Wang H
International Journal of General Medicine 2022, 15:4209-4220
Published Date: 20 April 2022
Clinicopathological Difference and Survival Impact of Patients with c-SCLC and SCLC
Zhang C, Shang X, Sun J, Li Z, Lin J, Zhao C, Wang H
International Journal of General Medicine 2021, 14:6899-6906
Published Date: 18 October 2021
Total Lymphocyte Count, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio as Prognostic Factors in Advanced Non-Small Cell Lung Cancer with Chemoradiotherapy [Corrigenudm]
Song X, Chen D, Yuan M, Wang H, Wang Z
Cancer Management and Research 2021, 13:1135-1136
Published Date: 5 February 2021
High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells
Ning Z, Zhu Z, Wang H, Zhang C, Xu L, Zhuang L, Yan X, Wang D, Wang P, Meng Z
OncoTargets and Therapy 2019, 12:1161-1170
Published Date: 12 February 2019
Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy
Song X, Chen D, Yuan M, Wang H, Wang Z
Cancer Management and Research 2018, 10:6677-6683
Published Date: 5 December 2018
Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
Song X, Chen D, Guo J, Kong L, Wang H, Wang Z
OncoTargets and Therapy 2018, 11:8421-8426
Published Date: 27 November 2018
PLNR≤20% may be a benefit from PORT for patients with IIIA-N2 NSCLC: a large population-based study
Shang X, Li Z, Lin J, Wang H, Wang Z
Cancer Management and Research 2018, 10:3561-3567
Published Date: 17 September 2018
Surgical intervention may be a therapeutic option for NSCLC patients with AJCC stage IV: a large population-based study
Wang H, Yan L, Li C, Wang Z
Cancer Management and Research 2018, 10:3219-3226
Published Date: 4 September 2018
Screening differential circular RNA expression profiles reveal that hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of hepatocellular carcinoma
Chen DW, Zhang CY, Lin JM, Song XY, Wang HY
Cancer Management and Research 2018, 10:1275-1283
Published Date: 18 May 2018
How many ELNs are optimal for breast cancer patients with more than three PLNs who underwent MRM? A large population-based study
Wang X, Ji C, Chi H, Wang H
OncoTargets and Therapy 2018, 11:1005-1011
Published Date: 26 February 2018
Prognostic nutritional index serves as a predicative marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2016, 9:6417-6423
Published Date: 19 October 2016
Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review
Wang HY, Zhu H, Kong L, Yu JM
OncoTargets and Therapy 2016, 9:4639-4644
Published Date: 26 July 2016